SetPoint Medical Raises $30M

Valencia-based SetPoint Medical, which develops bioelectronic therapy to treat chronic inflammatory diseases, said today that it has raised $30M in its Series D funding. The funding came from existing investors, including NEA, Morgenthaler, Medtronic, Boston Scientific, Topspin, Action Potential Venture Capital and others. Setpoint, which is led by CEO Anthony Arnold, said the new funding will go to advance clinical development of its product. More information »